STOCK TITAN

Tenet Healthcare director sells $298K in stock

TENET HEALTHCARE CORP (THC) director Nadja West reported selling 1,152 shares of common stock on September 2, 2026 in a sale described as an open market or private transaction at $258.80 per share.

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

TENET HEALTHCARE CORP (THC) director Nadja West reported selling 1,152 shares of common stock on September 2, 2026 in a sale described as an open market or private transaction at $258.80 per share. After this transaction, she reported directly holding 23,653 shares of Tenet Healthcare common stock. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider West Nadja
Role Director
Sold 1,152 shs ($298K)
Type Security Shares Price Value
Sale Common Stock 1,152 $258.80 $298K
Holdings After Transaction: Common Stock — 23,653 shares (Direct)
Shares sold 1,152 shares Common stock sale on September 2, 2026
Sale price per share $258.80 per share Common stock sale on September 2, 2026
Approximate transaction value $298,137.60 1,152 shares sold at $258.80 per share
Shares held after transaction 23,653 shares Direct holdings after September 2, 2026 sale
Net shares sold 1,152 shares Net share change across all reported transactions in this Form 4
open market financial
"Sale in open market or private transaction"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
private transaction financial
"Sale in open market or private transaction"
A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.
Rule 10b5-1 trading plan regulatory
"No Rule 10b5-1 trading plan is reported"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

What insider transaction did THC director Nadja West report?

Nadja West reported a sale of 1,152 shares of Tenet Healthcare common stock on September 2, 2026, in a transaction described as an open market or private transaction at $258.80 per share.

How many THC shares does Nadja West hold after this Form 4 transaction?

After the reported sale, Nadja West directly holds 23,653 shares of Tenet Healthcare common stock. This figure reflects the position reported following the September 2, 2026 transaction.

What was the total value of the THC shares sold by Nadja West?

Based on the reported sale of 1,152 shares at $258.80 per share, the transaction value is approximately $298,137.60. This is a straightforward multiplication of the disclosed share count and price per share.

Was Nadja West’s THC share sale under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, indicating the reported September 2, 2026 sale was not affirmed as being made pursuant to a Rule 10b5-1 trading plan.

What type of transaction was reported in this THC Form 4?

The Form 4 reports a sale of common stock, coded as a disposition in a non-derivative transaction. The description states it was a sale in open market or private transaction on September 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
West Nadja

(Last)(First)(Middle)
14201 DALLAS PARKWAY

(Street)
DALLAS TEXAS 75254

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/02/2026S1,152D$258.823,653D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Chad J. Wiener, as Attorney-in-fact for Nadja West09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)